Tevogen Bio Shareholders Approve Governance-Enhancing Charter ChangesTip Ranks·Aug 26 at 07:27 PMTVGNW-6.48%TVGN-2.37%
Tevogen held annual shareholder meeting, stockholders voted on proposalsPUBT·Aug 26 at 07:18 PMTVGN-2.37%TVGNW-6.48%
Tevogen Inc. Q2 2026: Net loss $(5.84M), EPS $(1.52) — 10-Q SummaryTradingView·Aug 14 at 09:22 PMTVGN-2.37%TVGNW-6.48%
Tevogen Q2 FY26 net loss widens to $5.76 million; operating loss rises to $5.66 millionPUBT·Aug 14 at 09:19 PMTVGN-2.37%TVGNW-6.48%
Tevogen amends bylaws to reflect corporate name change to Tevogen IncPUBT·Jul 30 at 12:33 PMTVGN-2.37%TVGNW-6.48%
Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquiredrttnews·Jul 28 at 03:34 AMFBRX0.00%TVGNW-6.48%
Tevogen Bio Announces 2026 Annual Meeting of Stockholders | TVGN Stock NewsStockTitan·Jul 13 at 06:15 PMTVGNW-6.48%TVGN-2.37%
Tevogen Announces Formation of a Healthcare Services Initiative | TVGN Stock NewsStockTitan·Jun 9 at 11:30 AMTVGN-2.37%TVGNW-6.48%
Tevogen Advances Strategic Acquisition Plans With Potential To Add $100 Million In Annual Revenuenasdaq·May 29 at 05:35 AMTVGNW-6.48%TVGN-2.37%
